3200
M. D. Fryzuk et al. / Tetrahedron: Asymmetry 9 (1998) 3191–3202
1
For 3b: H NMR (CDCl3): δ 8.1 (d, 1H, J=7.0 Hz, pyridine), 7.2 (t, 1H, J=8.0 Hz, pyridine), 6.9
(d, 1H, J=10.0 Hz, pyridine), 6.7 (t, 1H, J=8.0 Hz, pyridine), 3.8 (m, 1H, CH, oxazoline), 3.6 (m, 2H,
CH2, oxazoline), 3.4 (s, 2H, CH2, aliphatic), 1.3 (m, 1H, CHMe2), 0.6 (d, 3H, J=12.0 Hz, CH3), 0.5 (d,
3H, J=12.0 Hz, CH3). 13C{1H} NMR: δ 164 (C-ipso), 155 (quat, oxazoline), 148 (o-C), 137 (m-C), 123
(p-C), 121 (m-C), 76 (CH2, oxazoline), 56 (CHMe2), 37 (CH2, aliphatic), 19 (CHMe2), 18 (CH3), 17
(CH3). Anal. calcd for C12H16N2O: C, 70.56; H, 7.89; N, 13.71. Found: C, 70.58; H, 7.85; N, 13.95.
1
For 3c: H NMR (CDCl3): δ 8.4 (d, 1H, J=10.0 Hz, pyridine), 7.3 (t, 1H, J=8.0 Hz, pyridine), 7.2
(d, 1H, J=10.0 Hz, pyridine), 7.0 (t, 1H, J=8.0 Hz, pyridine), 4.3 (m, 2H, CH2 oxazoline), 4.1 (m, 1H,
CH oxazoline), 3.7 (m, 2H, CH2 aliphatic), 1.4 (m, 2H, CH2CHMe2), 1.2 (m, 1H, CHMe2), 0.7 (d, 3H,
J=10.0 Hz, CH3), 0.6 (d, 3H, J=10.0 Hz, CH3). 13C{1H} NMR: 164 (C-ipso), 155 (quat, oxazoline), 149
(o-C), 137 (m-C), 123 (p-C), 122 (m-C), 77 (CH2, oxazoline), 64 (CHC4H9), 45 (CH2CHMe2), 37 (CH2,
aliphatic), 25 (CHMe2), 23 (CH3). Anal. calcd for C13H18N2O: C, 71.53; H, 8.31; N, 12.83. Found: C,
70.91; H, 7.94; N, 13.47.
4.3. Synthesis of {Rh(COD)[2-(2-(4,-R,4-R0)oxazolin-2-ylmethyl)pyridine]}PF6, 4a–c
[Rh(COD)Cl]2 (200 mg, 0.4 mmol) was dissolved in THF (30 ml) and a solution of AgPF6 (210 mg,
0.8 mmol) in THF (10 ml) was added to it. A yellow precipitate was formed immediately, the flask then
was covered with aluminum foil and the reaction mixture was stirred for 1 h. The precipitate (AgCl)
was filtered through Celite on a Schlenk frit. The solution of the ligand (160 mg, 0.8 mmol) in THF (10
ml) was degassed and added to the filtrate. The reaction mixture was then allowed to stir overnight. The
solvent evaporated under reduced pressure, the yellow powder was washed with hexanes and ether to
give yellow semi-crystalline solid which was recrystallized from 1:1.5:1.5 CH2Cl2:hexanes:ether (1.8 g,
81%).
For 4a, room temperature 1H NMR (CDCl3): δ 8.4 (d, 1H, J=6.0 Hz, pyridine), 7.9 (t, 1H, J=7.5 Hz,
pyridine), 7.6 (d, 1H, J=9.0 Hz, pyridine), 7.4 (t, 1H, J=6.0 Hz, pyridine), 4.7 (br s, 3H, CH2 oxazoline
and aliphatic), 4.2 (broad, 5H, CH COD and CH2 aliphatic), 2.5 (br s, 2H, CH2 COD), 1.9 (br s, 2H,
COD aliphatic), 1.3 (s, 6H, CH3). 1H NMR (d8-THF) at −90°C: δ 5.2 (δ, 1H, J=15 Hz, CH2 aliphatic),
4.9 (br s, 1H, CH2 oxazoline), 4.8 (br s, 1H, CH2 oxazoline), 4.4 (d, 1H, J=9.0 Hz, COD olefinic), 4.3
(d, 1H, J=15.0 Hz, CH2 aliphatic), 4.2 (br s, 1H, COD olefinic), 4.0 (d, 1H, J=9.0 Hz, COD olefinic),
3.9 (br s, 1H, COD olefinic), 1.3 (s, 3H, CH3), 1.2 (s, 3H, CH3). Anal. calcd for C19H26N2OPF6Rh: C,
41.77; H, 4.80; N, 5.13. Found: C, 41.74; H, 4.70; N, 4.98.
For 4b, 1H NMR (CDCl3): δ 8.4 (d, 1H, J=6.0 Hz, pyridine), 7.9 (t, 1H, J=7.5 Hz, pyridine), 7.6 (d,
1H, J=9.0 Hz, pyridine), 7.4 (t, 1H, J=6.0 Hz, pyridine), 4.9 (d, 1H, J=19.0 Hz, CH2 aliphatic), 4.6 (t,
1H, J=9.0 Hz, CH2 oxazoline), 4.3 (m, 2H, COD olefinic), 4.2 (br s, 2H, COD olefinic), 4.0 (d, 1H,
J=19.0 Hz, CH2 aliphatic), 3.8 (m, 1H, CH2 oxazoline), 2.7 (m, 2H, COD aliphatic), 2.4 (m, 3H, COD
aliphatic), 2.2 (br s, 3H, COD aliphatic), 1.9 (m, 1H, CHMe2), 1.8 (m, 1H, CH oxazoline), 0.8 (d, 3H,
J=10.0 Hz, CH3), 0.6 (d, 3H, J=10.0 Hz, CH3). Anal. calcd for C20H28N2OPF6Rh: C, 42.87; H, 5.04; N,
5.00. Found: C, 42.73; H, 5.06; N, 5.13.
1
For 4c, H NMR (CDCl3): δ 8.4 (d, 1H, J=6.0 Hz, pyridine), 7.9 (t, 1H, J=7.5 Hz, pyridine), 7.6
(d, 1H, J=9.0 Hz, pyridine), 7.4 (t, 1H, J=6.0 Hz, pyridine), 4.8 (m, 1H, CH2 aliphatic), 4.4 (m, 2H,
COD olefinic), 4.2 (d, 1H, J=20.0 Hz, CH2 aliphatic), 3.9 (m, 1H, CH2 oxazoline), 2.8 (m, 2H, COD
aliphatic), 2.5 (m, 3H, COD aliphatic), 2.3 (m, 3H, COD aliphatic), 1.8 (m, 2H, CH2CHMe2), 1.4 (m,
2H, CH oxazoline and CHMe2), 1.0 (d, 6H, J=10.0 Hz, CH3).